Tuesday, January 18, 2022 from 2 – 2:45 p.m. (ET)
Natural Killer (NK) Cells: Defenders Against Cancer
Considered the shock troops of the immune system, natural killer (NK) cells are the first wave of defenders against infection and disease. Researchers – including Dana-Farber Cancer Institute’s Rizwan Romee, MD – are discovering the unique capabilities of NK cells that give them potential as a potent cancer therapy. Join Dr. Romee and his Dana-Farber colleagues Glenn Hanna, MD, and Sarah Nikiforow, MD, PhD, in a conversation about Dana-Farber’s NK cell research to learn more about the immense promise this therapy has for future patients across several cancer types including hematologic, head and neck, and ovarian cancers. The virtual discussion will be moderated by Robert Soiffer, MD, and will include a live, interactive session for questions.